• OSCOTEC targets annual standalone R&D investment of at least KRW 21 billion by 2027.
• The licensing strategy targets at least five out-licensing deals by 2034.
• Dividends and bonus share issues face phased consideration, subject to distributable profits, adequate cash flow and an increased authorized share limit.
• Independent directors will comprise at least one-third of the board by the 2027 annual shareholders meeting.
• A sustainability report is planned for the first half of 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OSCOTEC Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261105900316), on November 05, 2026, and is solely responsible for the information contained therein.